In his research, Sharan Kumar Reddy Bobbala, PhD, used lipid nanoparticles to deliver adjuvants, which are molecules in vaccines that work to stimulate the immune system — directly to white blood cells.
This method, Dr. Bobbala said in the Feb. 21 news release, could “allow enhanced and more durable immune responses with lower vaccine doses.”
